Literature DB >> 21791169

Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations.

Nadine Donata Wolf1, Fabio Sambataro, Nenad Vasic, Karel Frasch, Markus Schmid, Carlos Schönfeldt-Lecuona, Philipp Arthur Thomann, Robert Christian Wolf.   

Abstract

BACKGROUND: Functional neuroimaging studies on schizophrenia have suggested abnormal task-related functional connectivity in patients with schizophrenia who have auditory verbal hallucinations (AVHs). However, little is known about intrinsic functional connectivity in these patients.
METHODS: Between January 2009 and February 2010, we studied patients with schizophrenia who had persistent and treatment-refractory AVHs in comparison with healthy controls. Using functional magnetic resonance imaging, we studied the functional connectivity of multiple resting state networks (RSNs) and their relation to symptom severity. We analyzed the data using a spatial group independent component analysis, and we used random-effects t tests to compare spatial components between groups.
RESULTS: There were 10 patients and 14 controls enrolled in this study. In total, 16 RSNs were identified, from which we selected 4 networks of interest for further analyses. Within a speech-related network, patients showed increased connectivity in bilateral temporal regions and decreased connectivity in the cingulate cortex. Within 2 additional RSNs associated with attention and executive control, respectively, patients exhibited abnormal connectivity in the precuneus and right lateral prefrontal areas. We found correlations between measures of AVH severity and functional connectivity of the left anterior cingulate, left superior temporal gyrus and right lateral prefrontal cortex. LIMITATIONS: The relatively small sample size, the patients' use of antipsychotic medication and the lack of a clinical control group have to be considered as potential limitations.
CONCLUSION: Our findings indicate that disrupted intrinsic connectivity of a speech-related network could underlie persistent AVHs in patients with schizophrenia. In addition, the occurrence of hallucinatory symptoms seems to modulate RSNs associated with attention and executive control.
© 2011 Canadian Medical Association

Entities:  

Mesh:

Year:  2011        PMID: 21791169      PMCID: PMC3201990          DOI: 10.1503/jpn.110008

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  60 in total

Review 1.  The anatomy of language: contributions from functional neuroimaging.

Authors:  C J Price
Journal:  J Anat       Date:  2000-10       Impact factor: 2.610

Review 2.  Exploring the brain network: a review on resting-state fMRI functional connectivity.

Authors:  Martijn P van den Heuvel; Hilleke E Hulshoff Pol
Journal:  Eur Neuropsychopharmacol       Date:  2010-05-14       Impact factor: 4.600

3.  On redefining hallucination.

Authors:  A Aleman; E H de Haan
Journal:  Am J Orthopsychiatry       Date:  1998-10

4.  Anterior cingulate cortex, error detection, and the online monitoring of performance.

Authors:  C S Carter; T S Braver; D M Barch; M M Botvinick; D Noll; J D Cohen
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

5.  Aberrant "default mode" functional connectivity in schizophrenia.

Authors:  Abigail G Garrity; Godfrey D Pearlson; Kristen McKiernan; Dan Lloyd; Kent A Kiehl; Vince D Calhoun
Journal:  Am J Psychiatry       Date:  2007-03       Impact factor: 18.112

6.  Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study.

Authors:  Toshiaki Onitsuka; Martha E Shenton; Dean F Salisbury; Chandlee C Dickey; Kiyoto Kasai; Sarah K Toner; Melissa Frumin; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

Review 7.  Are anticorrelated networks in the brain relevant to schizophrenia?

Authors:  Peter Williamson
Journal:  Schizophr Bull       Date:  2007-05-10       Impact factor: 9.306

8.  Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.

Authors:  Eduard Parellada; Francisco Lomena; Mireia Font; Deborah Pareto; Fernando Gutierrez; Marc Simo; Emili Fernández-Egea; Javier Pavia; Domenec Ros; Miquel Bernardo
Journal:  Nucl Med Commun       Date:  2008-10       Impact factor: 1.690

Review 9.  The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations.

Authors:  Paul Allen; Frank Larøi; Philip K McGuire; Andrè Aleman
Journal:  Neurosci Biobehav Rev       Date:  2007-08-15       Impact factor: 8.989

10.  Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations.

Authors:  Stephen M Lawrie; Christian Buechel; Heather C Whalley; Christopher D Frith; Karl J Friston; Eve C Johnstone
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

View more
  53 in total

1.  The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity.

Authors:  Luis M Colon-Perez; Kelvin Tran; Khalil Thompson; Michael C Pace; Kenneth Blum; Bruce A Goldberger; Mark S Gold; Adriaan W Bruijnzeel; Barry Setlow; Marcelo Febo
Journal:  Neuropsychopharmacology       Date:  2016-03-21       Impact factor: 7.853

2.  Discrimination of schizophrenia auditory hallucinators by machine learning of resting-state functional MRI.

Authors:  Darya Chyzhyk; Manuel Graña; Döst Öngür; Ann K Shinn
Journal:  Int J Neural Syst       Date:  2015-01-19       Impact factor: 5.866

3.  Deviations in cortex sulcation associated with visual hallucinations in schizophrenia.

Authors:  A Cachia; A Amad; J Brunelin; M-O Krebs; M Plaze; P Thomas; R Jardri
Journal:  Mol Psychiatry       Date:  2014-10-28       Impact factor: 15.992

Review 4.  [Cognitive control in the research domain criteria system: clinical implications for auditory verbal hallucinations].

Authors:  Katharina M Kubera; Dusan Hirjak; Nadine D Wolf; Robert C Wolf
Journal:  Nervenarzt       Date:  2021-08-03       Impact factor: 1.214

5.  Disruptions in the left frontoparietal network underlie resting state endophenotypic markers in schizophrenia.

Authors:  George Chahine; Anja Richter; Sarah Wolter; Roberto Goya-Maldonado; Oliver Gruber
Journal:  Hum Brain Mapp       Date:  2016-12-23       Impact factor: 5.038

Review 6.  Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.

Authors:  Shinichiro Nakajima; Hiroyoshi Takeuchi; Eric Plitman; Gagan Fervaha; Philip Gerretsen; Fernando Caravaggio; Jun Ku Chung; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Schizophr Res       Date:  2015-02-13       Impact factor: 4.939

7.  Resting state EEG power and coherence abnormalities in bipolar disorder and schizophrenia.

Authors:  Julia W Y Kam; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick; Colleen A Brenner
Journal:  J Psychiatr Res       Date:  2013-09-20       Impact factor: 4.791

8.  Abnormal Local Activity and Functional Dysconnectivity in Patients with Schizophrenia Having Auditory Verbal Hallucinations.

Authors:  Cheng Chen; Gao-Hua Wang; Shi-Hao Wu; Ji-Lin Zou; Yuan Zhou; Hui-Ling Wang
Journal:  Curr Med Sci       Date:  2020-10-29

9.  Chronic postnatal chemogenetic activation of forebrain excitatory neurons evokes persistent changes in mood behavior.

Authors:  Kamal Saba; Sonali S Salvi; Sthitapranjya Pati; Praachi Tiwari; Pratik R Chaudhari; Vijaya Verma; Sourish Mukhopadhyay; Darshana Kapri; Shital Suryavanshi; James P Clement; Anant B Patel; Vidita A Vaidya
Journal:  Elife       Date:  2020-09-21       Impact factor: 8.140

10.  Functional connectivity of left Heschl's gyrus in vulnerability to auditory hallucinations in schizophrenia.

Authors:  Ann K Shinn; Justin T Baker; Bruce M Cohen; Dost Ongür
Journal:  Schizophr Res       Date:  2012-12-31       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.